Brean Capital Reiterates Buy Rating, Raises PT On Medivation As Xtandi Deserves To Move Upstream
March 25, 2015 at 10:36 AM EDT
In a report published Wednesday, Brean Capital analyst Jonathan Aschoff reiterated a Buy rating on Medivation, Inc. (NASDAQ: MDVN), and ...